PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway
Cellular Signalling · 2023
DOI: 10.1016/j.cellsig.2023.110736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2023. Verfasst von Xiaoxuan Duan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan Province 450001, PR China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Esophageal squamous carcinoma (ESCC) with a high incidence in China, lacks effective therapeutic targets. Phosphoglycerate dehydrogenase (PHGDH) is a key enzyme in serine biosynthesis. However, the biological role of PHGDH in ESCC has not been revealed. METHODS: The expression of PHGDH in ESCC was investigated by UALCAN. The relationship between PHGDH expression and its prognostic value was analyzed by Kaplan-Meier and univariate Cox regression. Further, the potential functions of PHGDH involved in ESCC were explored through DAVID database and GSEA software. In addition, the expression of PHGDH was verified in ESCC. Then, the effects of PHGDH knockdown on ESCC were evaluated in vitro and in vivo by cell proliferation, clone formation, cell cycle, apoptosis, tube formation assays and ESCC cells derived xenograft model. In addition, western blotting and immunohistochemistry were used to detect the expression of Wnt/β-catenin pathway which was associated with PHGDH. RESULTS: Bioinformatics analysis found that PHGDH was highly expressed in ESCC, and meaningfully, patients with high PHGDH expression had a poor prognosis. Moreover, the overexpression of PHGDH was verified in ESCC. Afterwards, PHGDH knockdown inhibited the cell proliferation, induced cell cycle arrest and apoptosis in ESCC cells, and inhibited the angiogenesis of HUVECs induced by ESCC conditioned medium, as well as inhibited the growth of xenograft tumor. Mechanistically, PHGDH knockdown inhibited Wnt/β-catenin signaling pathway in ESCC. CONCLUSION: High expression of PHGDH predicts a poor prognosis for ESCC. PHGDH knockdown inhibits ESCC progression by suppressing Wnt/β-catenin signaling pathway, indicating that PHGDH might be a potential target for ESCC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan Province 450001, PR China.
- Department of Oncology, Changzhi People's Hospital, Changzhi, Shanxi 046000, PR China.
- Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan Province 450001, PR China; Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou…
Zitieren
APA
Duan, X., Chen, Y., Zhang, K., Chen, W., Zhao, J., Dai, X., Cao, W., Dong, Z., Mo, S., & Lu, J. (2023). PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2023.110736
Vancouver
Duan X, Chen Y, Zhang K, Chen W, Zhao J, Dai X, et al. PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway. Cellular Signalling. 2023. doi:10.1016/j.cellsig.2023.110736
BibTeX
@article{Duan2023,
author = {Duan, Xiaoxuan and Chen, Yihuan and Zhang, Kai and Chen, Wei and Zhao, Jun and Dai, Xiaoshuo and Cao, Wenbo and Dong, Ziming and Mo, Saijun and Lu, Jing},
title = {PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway},
journal = {Cellular Signalling},
year = {2023},
doi = {10.1016/j.cellsig.2023.110736}
}
EUVIMED